Effects of K‐12 School District Nonpharmaceutical Interventions on Community‐Level Prevalence of Acute Respiratory Infection During the COVID‐19 Pandemic
Influenza and Other Respiratory Viruses · 2025
DOI: 10.1111/irv.70139 ↗Kurz gefasst
Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, 2025. Verfasst von C He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine and Community Health, University of Wisconsin, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: COVID-19, Respiratory Tract Infections. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCEZID CDC HHS, School of Medicine and Public Health, University of Wisconsin-Madison, Centers for Disease Control and Prevention (CDC).
Abstract (Originalsprache)
Background
Responding to the COVID‐19 pandemic, kindergarten through 12th grade schools implemented nonpharmaceutical interventions (NPIs). The effects of school‐based NPIs on broader community levels of acute respiratory infection (ARI) have not been defined. We utilized an existing longitudinal cohort of households reporting weekly ARI cases to evaluate the effects of evolving school districtwide NPIs on ARI activity at eight transition points from December 2019 through October 2022.
Methods
Household ARI data were reported through the GReat Oregon Child Absenteeism due to Respiratory Disease Study (ORCHARDS) Vaccine Effectiveness Study—a prospective cohort study based in the Oregon School District (OSD) (GROVES). Participating GROVES families completed weekly online surveys with respiratory illness updates. Mixed effects logistic regression was used to examine the association between eight school‐related transition events during the COVID‐19 pandemic and changes in the trajectory of ARI risk for GROVES family members, while accounting for family clusters. Transition events were assessed using a ±4‐week window of community data.
Results
Opening schools with maximal NPIs (mandated masking and physical distancing, with hybrid education) was not associated with increased community ARI activity. The four transition events associated with significant ARI risk trajectory increases included summer breaks (June 2020, p = 0.001; June 2021, p = 0.002), and the start of school with mandatory masking only (September 2021, p < 0.001) or without NPIs (September 2022, p < 0.001).
Conclusions
School‐based NPI implementation was associated with reduced risks for community ARI activity. Enhanced surveillance platforms such as the weekly online surveys used in this study are valuable tools for better understanding and monitoring SARS‐CoV‐2 and respiratory virus transmission in schools and surrounding communities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Family Medicine and Community Health, University of Wisconsin, Madison, Wisconsin, USA.
- Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, Wisconsin, USA.
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Förderung
- NCEZID CDC HHS
- School of Medicine and Public Health, University of Wisconsin-Madison
- Centers for Disease Control and Prevention (CDC)
Zitieren
APA
He, C., Goss, M. D., Norton, D., Chen, G., Uzicanin, A., & Temte, J. L. (2025). Effects of K‐12 School District Nonpharmaceutical Interventions on Community‐Level Prevalence of Acute Respiratory Infection During the COVID‐19 Pandemic. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.70139
Vancouver
He C, Goss MD, Norton D, Chen G, Uzicanin A, Temte JL. Effects of K‐12 School District Nonpharmaceutical Interventions on Community‐Level Prevalence of Acute Respiratory Infection During the COVID‐19 Pandemic. Influenza and Other Respiratory Viruses. 2025. doi:10.1111/irv.70139
BibTeX
@article{He2025,
author = {He, C and Goss, M D and Norton, D and Chen, G and Uzicanin, A and Temte, J L},
title = {Effects of K‐12 School District Nonpharmaceutical Interventions on Community‐Level Prevalence of Acute Respiratory Infection During the COVID‐19 Pandemic},
journal = {Influenza and Other Respiratory Viruses},
year = {2025},
doi = {10.1111/irv.70139}
}
EUVIMED